CYB003

A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing 2 Active Doses of CYB003 and Placebo in Eligible Participants with Major Depressive Disorder (EMBRACE)

A Phase III Long-Term Extension Trial with Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants with Major Depressive Disorder (EXTEND)